Benzinga | Feb 25, 2021 07:12AM EST

Concert Pharmaceuticals Q4 EPS $(0.69) Beats $(0.78) Estimate, Sales $7.00K Down From $13.00K YoY

Concert Pharmaceuticals (NASDAQ:CNCE) reported quarterly losses of $(0.69) per share which beat the analyst consensus estimate of $(0.78) by 11.54 percent. This is a 19.77 percent increase over losses of $(0.86) per share from the same period last year. The company reported $7.00 thousand in sales this quarter. This is a 46.15 percent decrease over sales of $13.00 thousand the same period last year.